SAKAR.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (9 May 2024 @ 05:59):

Stats
Today's Volume	123 100
Average Volume	26 543.00
Market Cap	7.44B
EPS	INR0 ( 2024-02-12 )
Next earnings date	( INR0 ) 2024-05-19
Last Dividend	INR0 ( N/A )
Next Dividend	INR0 ( N/A )
P/E	54.52
ATR14	INR1.319 (0.39%)

Volume Correlation

Long: 0.39 (neutral)

Short: -0.81 (strong negative)

Signal:(46.435) Neutral

Sakar Healthcare Limited Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sakar Healthcare Limited Correlation - Currency/Commodity

-0.77
( moderate negative )

-0.78
( moderate negative )

-0.67
( moderate negative )

-0.83
( strong negative )

0.76
( moderate )

0.64
( weak )

Sakar Healthcare Limited Financials

Annual	2022
Revenue:	INR1.33B
Gross Profit:	INR598.12M (44.85 %)
EPS:	INR6.86

FY	2022
Revenue:	INR1.33B
Gross Profit:	INR598.12M (44.85 %)
EPS:	INR6.86

FY	2022
Revenue:	INR1.28B
Gross Profit:	INR534.12M (41.65 %)
EPS:	INR890.22

FY	2021
Revenue:	INR947.39M
Gross Profit:	INR432.46M (45.65 %)
EPS:	INR7.09

Financial Reports:

No articles found.

Sakar Healthcare Limited

Sakar Healthcare Limited research, develops, manufactures, and markets pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectable SVP in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in approximately 22 therapeutic areas, such as antacid, antimalerial, anticoagulant, laxative, anthelmintic, bronchodilator, anaesthetic, antidepressant, sedative, adrenergic, anti-infective, diuretics, oxytocic, analgesic, antiemetic, antipsychotic, antifungal, PPI, anticonvulsant, anti-inflammatory, antihistamine, and multi vitamins. The company also exports its products to approximately 38 countries, including Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.